Table 2.
Estimates of cancer incidence in Aboriginal males, NSW, 1999-2007, and risk comparison with non-Aboriginal males
| Cancer site | Registered cases | Missing (%) | Imputed cases | Imputed incidence3 per 100,000 (95% CI) | SIR1(95% CI) | Risk2 to age 75, 1 in: | |
|---|---|---|---|---|---|---|---|
| |
|
|
|
|
|
Aboriginal |
Non-Aboriginal |
| Head and neck |
96 |
6.4 |
103 |
37.9 (28.5-47.2) |
2.05 (1.64-2.46) |
34 |
59 |
| Oesophagus |
27 |
2.2 |
28 |
13.6 (7.5-19.7) |
1.85 (1.15-2.54) |
86 |
174 |
| Stomach |
46 |
3.1 |
47 |
25.5 (16.7-34.3) |
1.85 (1.32-2.38) |
54 |
107 |
| Large bowel |
147 |
6.4 |
158 |
75.4 (60.6-90.3) |
1.06 (0.88-1.23) |
17 |
17 |
| Liver |
29 |
2.1 |
30 |
11.7 (6.9-16.6) |
1.67 (1.06-2.27) |
81 |
172 |
| Pancreas |
32 |
1.1 |
32 |
17.7 (10.2-25.1) |
1.53 (1.00-2.06) |
87 |
124 |
| Lung |
200 |
2.1 |
206 |
111.0 (92.6-129.4) |
1.93 (1.66-2.19) |
12 |
23 |
| Melanoma of skin |
37 |
41.2 |
67 |
33.6 (21.3-45.9) |
0.44 (0.29-0.58) |
48 |
23 |
| Mesothelioma |
11 |
1.7 |
11 |
7.4 (2.4-12.5) |
1.32 (0.54-2.10) |
211 |
276 |
| Prostate |
183 |
20.0 |
239 |
144.5 (120.0-169.0) |
0.82 (0.71-0.94) |
10 |
8 |
| Kidney |
50 |
9.1 |
53 |
24.1 (15.9-32.4) |
1.31 (0.95-1.66) |
60 |
73 |
| Bladder |
30 |
5.3 |
31 |
23.3 (13.7-33.0) |
1.07 (0.69-1.45) |
105 |
87 |
| Brain |
20 |
2.8 |
21 |
5.5 (2.2-8.8) |
0.74 (0.42-1.07) |
262 |
150 |
| Non-Hodgkin’s lymphoma |
47 |
10.2 |
53 |
17.1 (11.4-22.7) |
0.95 (0.68-1.22) |
62 |
60 |
| Multiple myeloma |
17 |
6.3 |
18 |
9.1 (3.9-14.2) |
1.24 (0.65-1.83) |
130 |
180 |
| All leukaemias |
51 |
8.6 |
56 |
23.8 (15.0-32.5) |
1.06 (0.77-1.35) |
70 |
83 |
| Unknown primary |
59 |
4.7 |
61 |
30.1 (20.7-39.5) |
1.63 (1.21-2.05) |
47 |
77 |
| Myelodysplasia |
27 |
6.1 |
29 |
18.1 (9.7-26.4) |
1.50 (0.94-2.07) |
118 |
157 |
| All cancers | 1,201 | 13.6 | 1,347 | 660.2 (613.7-706.6) | 1.09 (1.02-1.15) | 2.6 | 2.8 |
1Standardised incidence ratio in relation to all NSW males.
2Cumulative risk.
3Directly age-standardised to 2001 Australian census population.